Year To Quarter End Statement Of Income

Carna Biosciences, Inc. - Filing #7712030

Concept 2019-01-01 to
2019-03-31
2019-01-01 to
2019-03-31
2019-01-01 to
2019-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
2018-01-01 to
2018-03-31
Year to quarter end statement of income
Statement of income
Net sales
169,964,000 JPY
169,964,000 JPY
JPY
211,132,000 JPY
JPY
211,132,000 JPY
Cost of sales
43,917,000 JPY
65,297,000 JPY
Gross profit (loss)
126,046,000 JPY
145,835,000 JPY
Selling, general and administrative expenses
359,166,000 JPY
334,709,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-233,119,000 JPY
30,494,000 JPY
-263,614,000 JPY
-188,874,000 JPY
-253,452,000 JPY
64,578,000 JPY
Non-operating income
Interest income
5,000 JPY
8,000 JPY
Dividend income
93,000 JPY
90,000 JPY
Non-operating income
652,000 JPY
639,000 JPY
Non-operating expenses
Interest expenses
2,074,000 JPY
2,623,000 JPY
Non-operating expenses
3,415,000 JPY
3,099,000 JPY
Ordinary profit (loss)
-235,883,000 JPY
-191,334,000 JPY
Extraordinary losses
Impairment losses
JPY
2,172,000 JPY
Extraordinary losses
JPY
2,172,000 JPY
Profit (loss) before income taxes
-235,883,000 JPY
-193,506,000 JPY
Income taxes - current
970,000 JPY
1,016,000 JPY
Income taxes - deferred
-38,000 JPY
-41,000 JPY
Income taxes
931,000 JPY
974,000 JPY
Profit (loss)
-236,814,000 JPY
-194,481,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.